Body & Fitness

Two babies with leukemia in remission after trialling new gene therapy

Both children were given a new, experimental treatment and have been in remission for more than a year.

Two babies suffering from childhood leukemia have gone into remission following a groundbreaking medical trial.

While British researchers may not have found what causes leukemia in children, they have made a breakthrough in the way we could be able to treat it in the future.

According to a research paper published in the Science Translational Medicine journal, two babies given an experimental kind of edited T-cells are now in remission.

Both children, little girls aged 11 months and 16 months, respectively, were given the CAR-T cell therapy, as well as chemotherapy and bone marrow transplants (the latter was used to later flush the edited cells from their bodies), as a last attempt at saving their lives from the cancer.

Since their treatments, which occurred between June and December 2015, Medical Xpress report that young girls are with their families, happy and healthy.

This treatment was experimental and not approved for wider use, however various forms of CAR-T cell therapy are being trialed, and being dubbed by experts as [“promising”](https://medicalxpress.com/news/2017-01-leukemia-babies-remission-kind-t-cells.html |target=”_blank”|rel=”nofollow”).

Related stories